Morgan Woods Email & Phone Number

New York, NY, US

• Plan and perform chronic and sub-chronic Toxilogical GLP dietary and various dosing route studies in rodents
• Perform medical device implantation studies for toxilogical evaluation in rabbits
• Writing GLP protocols
• Necropsy/Prosection

• Performed acute and chronic in vivo pharmacology studies at a CRO for internal partners and external clients.
• Oral lipid tolerance test studies in mice for evaluation of novel compounds for NASH.
• Oncology studies in mice (immune compromised and not), with cancer cell inoculations, tumor measurements
• Ulcerative-colitis model studies in mice
• Experimental Autoimmune Encephalomyelitis model in mice
• IVIS (In Vivo Imaging System)

• Extensive experience running acute, intensive compound in vivo screens in various strains of mice and rats intended for the treatment of Type 2 diabetes. Extensive experience in new model development to further explore.
• In vivo drug activity/efficacy screening for Type 2 diabetes and obesity targets
• Glucose tolerance assays in mice and rats
• Dosing and rodent surgeries
• Feed intake studies in rodents
• Data evaluation and reporting

• Tested novel compounds in various strains of mice and rats intended for the treatment of Type 2 diabetes and compounds intended for the treatment of obesity. The glucose tolerance assay was the in vivo model most often.
• In vivo drug activity/efficacy screening for Type 2 diabetes and obesity targets
• Glucose tolerance assays in mice and rats
• Feed intake studies
• Hyperglycemic, Euglycemic and Hyperinsulinemic-Euglycemic clamps in rats and mice
• Dosing and rodent surgeries

• Tested novel compounds intended for the treatment of urinary incontinence in rat models of Neurogenic and Myogenic urinary bladder instability
• Assessed the in vivo hemodynamic effects of compounds in rats with radio telemetry
• In vivo drug activity/efficacy screening
• Telemetry
• Dosing, survival surgeries in rats, vessel cannulations, chronic transmitter implantation
• Data evaluation and reporting

• Using molecular biology to clone genes of interest from cDNA libraries for use in high throughput screening and in the construction of expression vectors for transgenic expression in mice. Micro-injecting fertilized.
• Molecular Biology o PCRo Cloning from cDNA librarieso BAC cloningo Nucleic acid extraction/purificationo Gel electrophoresiso Western blot analysiso Immunohistochemistryo Design of and use of RNAi (siRNA, shRNA)o Gene.
• Rodent survival surgeries
• Data evaluation and reporting 1996–2002 Research Scientist IWyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426 Tested novel compounds intended for the treatment of urinary incontinence in rat models of.
• In vivo drug activity/efficacy screening
• Dosing, survival surgeries in rats, vessel cannulations

• Tested novel compounds intended for the treatment of urinary incontinence in rat models of neurogenic, myogenic and isovolumetric urinary bladder instability. Assessed the in vivo hemodynamic effects of compounds in.
• In vivo drug activity/efficacy screening
• Dosing, survival surgeries in rats, vessel cannulations
• Data evaluation and reporting